Clinical Trial Update: A Study of Panobinostat in Pediatric Patients With Solid Tumors Including MRT/ATRT [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update for panobinostat in pediatric solid tumors including malignant rhabdoid tumor and atypical teratoid/rhabdoid tumor, noti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Teratoid Rhabdoid Tumor
• Brain Tumor
• Malignant Rhabdoid Tumor

Drugs mentioned

• Farydak (panobinostat)

Snippet

Sponsor: Australian & New Zealand Children's Haematology/Oncology Group | Conditions: Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor | Phase 2 | Status: TERMINATED